Skip to content

Comparison of the effect of infiltrative injection of ketorolac and articain on the success of inferior alveolar nerve block in mandibular molars with symptomatic irreversible pulpitis

Comparison of the effect of infiltrative injection of ketorolac and articain on the success of inferior alveolar nerve block in mandibular molars with symptomatic irreversible pulpitis a randomized double-blind clinial trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251018067669N1
Enrollment
44
Registered
2025-12-10
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symptomatic irreversible pulpitis.

Interventions

Intervention 1: Intervention group: infiltrative injection of ketorolac and lidocaine. Intervention 2: Control group: infiltrative injection of articaine.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: irreversible pulpitis mandibular molar healthy patient

Exclusion criteria

Exclusion criteria: History of any sensitivity or contraindication to nonsteroidal anti-inflammatory drugs or local anesthetics Pregnancy and breastfeeding Taking drugs that affect the central nervous system, such as alcohol or drugs Pain medication use in the past 24 hours Antidepressants or sedatives within the past four hours Cracked or broken teeth open apex Lack of soft tissue anesthesia after block injection Pain in more than one tooth Presence of an apical lesion with a diameter of more than one millimeter Liver or kidney problems active asthma Pulp necrosis

Design outcomes

Primary

MeasureTime frame
Increase the inferior alveolar nerve block. Timepoint: 1 hour. Method of measurement: visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad marvi sabagh

Tehran University of Medical Sciences

mohammadmarvi.68@gmail.com+98 912 394 9265

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026